跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,607 条关于
“Servier Pharma”
全部
12,607
临床试验
6,067
药物
1,261
机构
1,527
资讯
3,752
2年前
FDA Approves Oncomine Dx Target Test as Companion Diagnostic for Vorasidenib in IDH-Mutant Glioma
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Glioma, Developed from Duke Neurosurgeon's Discovery
2年前
Servier and Clariness Collaborate on Phase II Trial for Sjögren's Syndrome Drug
去年
Servier to Present Phase 3 Data on IDH-Mutated Cancer Therapies at ASCO 2025
去年
Black Diamond Therapeutics Completes Enrollment in Phase II Study of EGFR Inhibitor Silevertinib for NSCLC
3个月前
Servier to Present Long-Term VORANIGO Data and Novel ADC Results at ASCO 2026
去年
Trogenix Strengthens Leadership Team with Key Clinical Appointments as Odysseus Platform Advances Toward Clinical Trials
去年
STORM Therapeutics Initiates First-in-Class RNA Modification Therapy Combination Trial with Checkpoint Inhibitor
2年前
AI Revolutionizes Drug Discovery: Industry Leaders Share Latest Advances at London Conference
7个月前
Claudin 18.2 Targeted Therapy Market Set to Exceed $800 Million by 2030 as Pipeline Expands Beyond Gastric Cancer
第 1 页,共 376 页
上一页
下一页